Long-term outcome of surgical resection for residual or regrown advanced non-small cell lung carcinomas following EGFR-TKI treatment: report of four cases.

Abstract

We report the long-term outcome of 4 patients who underwent pulmonary resection for residual or regrown primary lesion of non-small cell lung cancer (NSCLC) treated with a epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) gefitinib. Two patients underwent surgical resection for localized regrown primary lesion after gefitinib for stage… (More)
DOI: 10.1007/s11748-014-0508-5

Topics

Cite this paper

@article{Hishida2016LongtermOO, title={Long-term outcome of surgical resection for residual or regrown advanced non-small cell lung carcinomas following EGFR-TKI treatment: report of four cases.}, author={Tomoyuki Hishida and Junji Yoshida and Keiju Aokage and Kanji Nagai and Masahiro Tsuboi}, journal={General thoracic and cardiovascular surgery}, year={2016}, volume={64 7}, pages={429-33} }